Overview

Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients

Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the pharmacokinetic (PK) profile of diluted insulin aspart (U25) with undiluted insulin aspart (U100) in school-aged children and adolescents with type 1 diabetes (T1D) utilizing the euglycemic clamp technique and a standardized meal in a controlled research environment. The investigators hypothesize that dilution of insulin aspart (U25) will alter the PK properties as compared to undiluted aspart.
Phase:
Early Phase 1
Details
Lead Sponsor:
Yale University
Treatments:
Insulin
Insulin Aspart
Insulin, Globin Zinc